Literature DB >> 4014379

Effects of eye rubbing on the conjunctiva as a model of ocular inflammation.

J V Greiner, D G Peace, R S Baird, M R Allansmith.   

Abstract

We assessed the effects of eye rubbing on the histologic characteristics and inflammatory cell infiltrate of the conjunctiva. The upper eyelids of 20 adult rats were rubbed during a five-minute period, and then the animals were killed immediately, or at four, eight, or 24 hours after trauma. One eye of each animal was rubbed; the unrubbed contralateral eye served as a control. Counts of mast cells, degranulated mast cells, and inflammatory cells (neutrophils, eosinophils, lymphocytes, plasma cells, and macrophages) were recorded from conjunctival samples from the upper eyelid. Immediately after eye rubbing the conjunctival epithelium was histologically disrupted and 50% of the mast cells showed evidence of degranulation. At four hours after trauma the increase in the number of neutrophils was more than 2,300%. Neutrophils were in the margins in the conjunctival vessels, had migrated into the substantia propria, and were aligned subjacent to the epithelial basement membrane; large numbers of neutrophils populated the epithelium. The four-hour stage was the most dramatic phase of inflammation that occurred from the eye rubbing. At 24 hours there was a significant increase in the number of macrophages. The numbers of lymphocytes, plasma cells, and eosinophils were not significantly changed throughout the study. Our findings demonstrate that eye rubbing histologically disrupts the epithelium and induces significant alteration in the inflammatory cell infiltrate of the conjunctiva. These changes may influence the course of ocular disease.

Entities:  

Mesh:

Year:  1985        PMID: 4014379     DOI: 10.1016/s0002-9394(14)74981-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Authors:  Alejandro Rodriguez-Garcia; Yolanda Macias-Rodriguez; Jose M Gonzalez-Gonzalez
Journal:  Int Ophthalmol       Date:  2017-06-10       Impact factor: 2.031

3.  The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Authors:  Koray Gumus; Dwight H Cavanagh
Journal:  Clin Ophthalmol       Date:  2009-06-02

4.  A randomized, fellow eye, comparison of keratometry, aberrometry, tear film, axial length and the anterior chamber depth after eye rubbing in non-keratoconic eyes.

Authors:  Jordan V Chervenkoff; Elizabeth Hawkes; Gabriela Ortiz; Deborah Horney; Mayank A Nanavaty
Journal:  Eye Vis (Lond)       Date:  2017-08-14

5.  Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model.

Authors:  Jobu Sugita; Yosuke Asada; Waka Ishida; Satoshi Iwamoto; Katsuko Sudo; Hajime Suto; Toru Matsunaga; Ken Fukuda; Atsuki Fukushima; Norihiko Yokoi; Tatsukuni Ohno; Miyuki Azuma; Nobuyuki Ebihara; Hirohisa Saito; Masato Kubo; Susumu Nakae; Akira Matsuda
Journal:  Immun Inflamm Dis       Date:  2017-07-20

6.  The Role of Atopy in the Choroidal Profile of Keratoconus Patients.

Authors:  Ana Filipa Moleiro; Ana Francisca Aires; Hélio Alves; João Viana Pinto; Ângela Carneiro; Fernando Falcão-Reis; Luís Figueira; João Pinheiro-Costa
Journal:  Clin Ophthalmol       Date:  2021-04-28

7.  Implications of a Diabetic Foot Xerosis Treatment With an Emulsion Containing the Plant-Based Anionic Phospholipids.

Authors:  Thomas Glonek; Jack V Greiner; Paula J Oliver; Terrance L Baker
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

Review 8.  Unraveling the mechanobiology of cornea: From bench side to the clinic.

Authors:  Shu Yang; Jing Zhang; Youhua Tan; Yan Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.